Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative

Raymond Borrow*, Jin Soo Lee, Julio A. Vázquez, Godwin Enwere, Muhamed Kheir Taha, Hajime Kamiya, Hwang Min Kim, Dae Sun Jo

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

34 Citations (Scopus)


The Global Meningococcal Initiative (GMI) is a global expert group that includes scientists, clinicians, and public health officials with a wide range of specialties. The purpose of the Initiative is to promote the global prevention of meningococcal disease (MD) through education, research, and cooperation. The first Asia-Pacific regional meeting was held in November 2014. The GMI reviewed the epidemiology of MD, surveillance, and prevention strategies, and outbreak control practices from participating countries in the Asia-Pacific region. Although, in general, MD is underreported in this region, serogroup A disease is most prominent in low-income countries such as India and the Philippines, while Taiwan, Japan, and Korea reported disease from serogroups C, W, and Y. China has a mixed epidemiology of serogroups A, B, C, and W. Perspectives from countries outside of the region were also provided to provide insight into lessons learnt. Based on the available data and meeting discussions, a number of challenges and data gaps were identified and, as a consequence, several recommendations were formulated: strengthen surveillance; improve diagnosis, typing and case reporting; standardize case definitions; develop guidelines for outbreak management; and promote awareness of MD among healthcare professionals, public health officials, and the general public.

Original languageEnglish
Pages (from-to)5855-5862
Number of pages8
Issue number48
Publication statusPublished - 21 Nov 2016

Bibliographical note

Funding Information:
The authors are all members of the Global Meningococcal Initiative (GMI). The GMI is funded by an educational grant from Sanofi Pasteur; however, the group is not led in any way by the company. GMI members determine meeting agenda items and lead the discussions and outputs. Sanofi Pasteur representatives may attend the meetings, but in the role of observers only, and they do not influence the findings of the group; nor do they write, review, or take part in the GMI’s decision to submit articles for publication.

Publisher Copyright:
© 2016


  • Asia-Pacific
  • Epidemiology
  • Global Meningococcal Initiative
  • Meningococcal disease
  • Recommendations
  • Surveillance


Dive into the research topics of 'Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative'. Together they form a unique fingerprint.

Cite this